18 min
5. The Clear Perspective on Creating New Products Let's Get CLEAR
-
- Investing
In this episode, Monica interviews Esa Oittinen, the Director of Product with Clear Cannabis, discussing product development in the cannabis industry. Esa shares his journey into product development, highlighting the exciting aspects of creating new products.
The discussion also touches on the difficulties of making consistent products due to variations in consumer biology. The conversation delves into the endocannabinoid system, discussing its role in maintaining homeostasis within the body and its interaction with cannabinoids. Esa emphasizes the importance of addressing these challenges, especially in light of potential regulatory changes and the need for consistency in cannabinoid products.
Monica and Esa explore different consumption formats, and how factors like food consumption can impact the effectiveness as well as what to look for on product labels. Esa covers upcoming product categories such as nasal sprays, and inhalers, as alternatives to traditional smoking or vaping. This episode provides valuable information on cannabis product development, consumption formats, and the challenges faced by the industry. It aims to empower listeners in making informed decisions about cannabis products for their specific needs.
Stay tuned for upcoming episodes where we unravel the mysteries of the venture capital world, explore industry trends, and share intriguing stories of new companies. Episodes incorporate relatable topics, thought-provoking conversations, and reliable information about cannabis, self-care, product trends, travel, wellness, teens, and everything in between. The Cliintel Capital team interviews special guests who offer a unique perspective on a wide range of subjects. Join us each week for fun, new adventures in venture capital, we hope will bring joy and enrich your life.
Follow Us:
Instagram: https://www.instagram.com/cliintel/
Facebook: https://www.facebook.com/Cliintel/
Website: https://cliintelcapital.com/
Linked In: https://www.linkedin.com/company/cliintel
X: https://twitter.com/Cliintel
In this episode, Monica interviews Esa Oittinen, the Director of Product with Clear Cannabis, discussing product development in the cannabis industry. Esa shares his journey into product development, highlighting the exciting aspects of creating new products.
The discussion also touches on the difficulties of making consistent products due to variations in consumer biology. The conversation delves into the endocannabinoid system, discussing its role in maintaining homeostasis within the body and its interaction with cannabinoids. Esa emphasizes the importance of addressing these challenges, especially in light of potential regulatory changes and the need for consistency in cannabinoid products.
Monica and Esa explore different consumption formats, and how factors like food consumption can impact the effectiveness as well as what to look for on product labels. Esa covers upcoming product categories such as nasal sprays, and inhalers, as alternatives to traditional smoking or vaping. This episode provides valuable information on cannabis product development, consumption formats, and the challenges faced by the industry. It aims to empower listeners in making informed decisions about cannabis products for their specific needs.
Stay tuned for upcoming episodes where we unravel the mysteries of the venture capital world, explore industry trends, and share intriguing stories of new companies. Episodes incorporate relatable topics, thought-provoking conversations, and reliable information about cannabis, self-care, product trends, travel, wellness, teens, and everything in between. The Cliintel Capital team interviews special guests who offer a unique perspective on a wide range of subjects. Join us each week for fun, new adventures in venture capital, we hope will bring joy and enrich your life.
Follow Us:
Instagram: https://www.instagram.com/cliintel/
Facebook: https://www.facebook.com/Cliintel/
Website: https://cliintelcapital.com/
Linked In: https://www.linkedin.com/company/cliintel
X: https://twitter.com/Cliintel
18 min